Novo Nordisk stock is being considered as a potential investment opportunity, with some outlets suggesting it is undervalued and deserves attention. The stock's current low price, near its 5-year low, and its dividend prospects are among the factors being discussed. However, not all investors are optimistic, with some retail investors reportedly showing dislike for the stock, leading to differing opinions on its potential as a long-term investment.